0001209191-19-049684.txt : 20190916
0001209191-19-049684.hdr.sgml : 20190916
20190916172841
ACCESSION NUMBER: 0001209191-19-049684
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190912
FILED AS OF DATE: 20190916
DATE AS OF CHANGE: 20190916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oien Jessica
CENTRAL INDEX KEY: 0001760712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 191095470
MAIL ADDRESS:
STREET 1: C/O CIDARA THERAPEUTICS, INC.
STREET 2: 6310 NANCY RIDGE DR, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-12
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001760712
Oien Jessica
C/O CIDARA THERAPEUTICS, INC.
6310 NANCY RIDGE DR, STE 101
SAN DIEGO
CA
92121
0
1
0
0
General Counsel & Secretary
Common Stock
2019-09-12
4
A
0
2800
0.00
A
8800
D
Restricted Stock Unit
2019-09-12
4
M
0
2800
0.00
D
Common Stock
2800
11200
D
This transaction relates to the vesting of shares upon the achievement of various clinical and corporate milestones that were previously reported in Table II of the Reporting Person's Form 4 filed 2/1/19.
Restricted stock units convert into common stock on a one-for-one basis.
A portion of the shares vest upon the achievement of various clinical and corporate milestones.
/s/ Jessica Oien
2019-09-16